|Bid||265.10 x 654700|
|Ask||257.40 x 41000|
|Day's Range||259.80 - 262.70|
|52 Week Range||168.20 - 271.00|
|PE Ratio (TTM)||-7.76|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The following are the top stories on the business pages of British newspapers. The credibility of an expert witness put up by the pharmaceuticals industry has been shot down by the National Institute for Health and Care Excellence in a legal row over drugs pricing, according to court papers obtained by the Times. A row over a confidential regulatory report into the activities of Royal Bank of Scotland Group Plc's restructuring division has descended into farce after television presenter Noel Edmonds claimed to have a copy.
Some RBS shareholders, who lost most of their money after a credit crisis-era rights issue, could receive less than a quarter of their settlement after litigation costs, according to a letter seen by Reuters. This highlights the price of bringing an unprecedented, U.S.-style group action in Britain for Royal Bank of Scotland shareholders, who have waited nine years for compensation after the bank's near collapse and state bailout in 2008. The RBoS Shareholders Action Group, whose members once topped 27,000, is one of five claimant groups that alleged investors were misled about the bank's financial strength when they bought shares at 200-230 pence.
Britain is in danger of losing its place in the financial world much in the same way Florence did after its Renaissance heyday, an industry group warned on Thursday. In statement ahead of Prime Minister Theresa May's speech on Brexit in the Italian city, TheCityUK, Britain's most powerful finance lobby said it was "crunch time" for finance firms. It cautioned that companies are already moving jobs overseas because of Britain's decision to leave the European Union, and further faltering in Brexit talks will lead to irreversible decisions.